After obtaining her doctor of pharmacy degree (Pharm.D.), Dr. Ravina Kullar completed a pharmacy practice residency at Detroit Receiving Hospital. Dr. Kullar remained in Detroit to complete a two and a half year Post-Doctoral Infectious Diseases Outcomes Pharmacotherapy Fellowship at Wayne State University, under the directorship of Dr. Michael Rybak and Dr. Susan Davis. During her fellowship, Dr. Kullar pursued a Masters in Public Health (MPH) degree at Wayne State University School of Medicine, which she expects to complete by 2012.
Dr. Kullar’s research interests include the evaluation of patient outcomes and costs associated with resistant organisms, such as methicillin-resistant Staphylococcus aureus (MRSA). She has been invited to present her research at both national and international research meetings. Examples of meetings at which her research has been presented both as poster and platform oral presentations include the Annual Infectious Disease Society of America (IDSA) meeting, the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meetings, the Society for Healthcare Epidemiology of America (SHEA) meeting, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) meeting. Additionally, Dr. Kullar has been awarded with several Infectious Diseases Fellows Travel Grants.
During her pharmacy practice residency and fellowship training, Dr. Kullar precepted and provided didactic therapeutic lectures to pharmacy students on various infectious diseases topics. She also served as a pharmacotherapy problem solving (PPS) facilitator to P3 students, an infectious diseases consult service co-preceptor to both pharmacy practice residents and pharmacy students, and lectured in therapeutic didactic modules in infectious diseases to pharmacy students.